Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

NCT00206219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Gefitinib
DRUG: methotrexate

Sponsor

AstraZeneca